The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Interim baseline characteristics from RIFTOS MKI, a global non-interventional study assessing the use of multikinase inhibitors (MKIs) in the treatment of patients with asymptomatic radioactive iodine-refractory differentiated thyroid cancer (RAI-R DTC).
 
Marcia S. Brose
Honoraria - Bayer; Exelixis; Onyx
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Exelixis; Onyx; Oxigene
Research Funding - Bayer (Inst); Eisai (Inst); Exelixis (Inst); Novartis (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Bayer; Eisai; Onyx
 
Fabian Pitoia
Consulting or Advisory Role - AstraZeneca; Bayer; Genzyme
Speakers' Bureau - AstraZeneca; Bayer; Genzyme
 
Johannes WA Smit
No Relationships to Disclose
 
Chia-Chi Lin
No Relationships to Disclose
 
Marc Mardoche Fellous
Employment - Bayer
 
Yoriko De Sanctis
Employment - Bayer
Stock and Other Ownership Interests - Bayer
 
Iwao Sugitani
Consulting or Advisory Role - Bayer
Speakers' Bureau - Bayer; Eisai; Sanofi
Research Funding - Eisai (Inst)
 
Martin Schlumberger
Consulting or Advisory Role - Bayer; Eisai; Ipsen; Sanofi